These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23909440)

  • 1. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis.
    Foulkes AC; Wheeler L; Gosal D; Griffiths CE; Warren RB
    Br J Dermatol; 2014 Jan; 170(1):206-9. PubMed ID: 23909440
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis.
    Aslam A; Green RL; Motta L; Ghrew M; Griffiths CE; Warren RB
    Br J Dermatol; 2013 Feb; 168(2):446-7. PubMed ID: 22816532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Splenic tuberculosis during psoriasis treatment with infliximab].
    Fortaleza GT; Brito Mde F; Santos JB; Figueiredo AR; Gomes P
    An Bras Dermatol; 2009; 84(4):420-4. PubMed ID: 19851677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.
    Wahie S; Alexandroff A; Reynolds NJ
    Clin Exp Dermatol; 2006 May; 31(3):460-1. PubMed ID: 16681606
    [No Abstract]   [Full Text] [Related]  

  • 5. The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.
    Nakao M; Asano Y; Nakamura K; Shida R; Takahashi T; Yoshizaki A; Mitsui A; Shibata S; Araki M; Watanabe R; Ikawa Y; Toyoda C; Oka H; Sato S
    Eur J Dermatol; 2016 Aug; 26(4):404-5. PubMed ID: 27086491
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.
    Kluger N; Girard C; Guillot B; Bessis D
    Acta Derm Venereol; 2009; 89(3):332-4. PubMed ID: 19479148
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab for psoriasis.
    Gottlieb AB
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S112-7. PubMed ID: 12894134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab.
    Vestergaard C; Deleuran M; Kragballe K
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1272-4. PubMed ID: 17894730
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of primary varicella infection during infliximab treatment for psoriasis.
    Balato N; Gaudiello F; Balato A; Ayala F
    J Am Acad Dermatol; 2009 Apr; 60(4):709-10. PubMed ID: 19293027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurological symptoms following infusion of infliximab].
    Bebe AC; Harboe KM; Nøjgaard C
    Ugeskr Laeger; 2012 Oct; 174(40):2388-90. PubMed ID: 23031302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe neutrophilia induced by infliximab for psoriasis.
    de Oliveira JP; Levy A; Morel P; Guibal F
    Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis.
    Diluvio L; Romiti ML; Angelini F; Campione E; Rossi P; Prinz JC; Chimenti S; Lamioni A
    Br J Dermatol; 2010 Apr; 162(4):895-7. PubMed ID: 20199542
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis.
    Ahmed Z; Powell R; Llewelyn G; Anstey A
    BMJ Case Rep; 2011 Dec; 2011():. PubMed ID: 22674940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urticarial vasculitis due do infliximab.
    Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute alveolitis following infliximab therapy for psoriasis.
    Bale J; Chee P
    Australas J Dermatol; 2013 Feb; 54(1):61-3. PubMed ID: 22780696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis.
    Gottlieb AB; Chaudhari U; Mulcahy LD; Li S; Dooley LT; Baker DG
    J Am Acad Dermatol; 2003 Jun; 48(6):829-35. PubMed ID: 12789171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.